Pages that link to "Q33655332"
Jump to navigation
Jump to search
The following pages link to IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L (Q33655332):
Displaying 50 items.
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy (Q26740207) (← links)
- Immune targeting of cancer stem cells in gastrointestinal oncology (Q26749015) (← links)
- Cytokine-Induced Modulation of Colorectal Cancer (Q26752374) (← links)
- Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview (Q26774619) (← links)
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations (Q28075712) (← links)
- From mice to humans: developments in cancer immunoediting (Q28088304) (← links)
- CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype (Q30353497) (← links)
- Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells (Q33648885) (← links)
- Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells (Q33702231) (← links)
- Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis (Q33755232) (← links)
- B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets (Q34311714) (← links)
- Role of interleukin-22 in inflammatory bowel disease (Q34456769) (← links)
- Mechanisms and applications of interleukins in cancer immunotherapy (Q34458290) (← links)
- Cancer stem cell plasticity and tumor hierarchy (Q34459650) (← links)
- Th22 cell accumulation is associated with colorectal cancer development (Q35375460) (← links)
- Interleukin-22: immunobiology and pathology (Q35530956) (← links)
- Epigenetic modifications of the immune system in health and disease (Q35558450) (← links)
- Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer. (Q35605854) (← links)
- Hypoxia-inducible factors in cancer stem cells and inflammation (Q35705992) (← links)
- Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth (Q35824820) (← links)
- Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases (Q36070332) (← links)
- Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells (Q36119064) (← links)
- The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target (Q36250669) (← links)
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. (Q36386431) (← links)
- PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer (Q36471461) (← links)
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy (Q36653748) (← links)
- The Role of IL-22 in Viral Infections: Paradigms and Paradoxes (Q36947949) (← links)
- Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. (Q36963408) (← links)
- LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression. (Q37208291) (← links)
- Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling (Q37224613) (← links)
- Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer (Q37602479) (← links)
- CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis (Q37706317) (← links)
- Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma (Q37709012) (← links)
- The JAK-STAT pathway: impact on human disease and therapeutic intervention (Q38317993) (← links)
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. (Q38539817) (← links)
- Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances (Q38554422) (← links)
- Emerging cytokine networks in colorectal cancer. (Q38584430) (← links)
- Emerging strategies for cancer immunoprevention (Q38585850) (← links)
- Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer (Q38602944) (← links)
- Therapeutic antibodies against cancer stem cells: a promising approach (Q38637435) (← links)
- The upstreams and downstreams of H3K79 methylation by DOT1L. (Q38686217) (← links)
- Biological and pathological activities of interleukin-22. (Q38753752) (← links)
- Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway (Q38768002) (← links)
- Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target (Q38772002) (← links)
- Identification of differentially expressed genes and their upstream regulators in colorectal cancer (Q38837129) (← links)
- IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients (Q38842154) (← links)
- Biological Response Modifier in Cancer Immunotherapy (Q38848213) (← links)
- Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival (Q38855371) (← links)
- Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy (Q39037708) (← links)
- Determinants of metastatic competency in colorectal cancer (Q39085740) (← links)